Company Biography
A Phase 2, Multi-Arm Study of Anti-CD47 Antibody Magrolimab in Combination with Docetaxel in Patients with Locally Advanced or Metastatic Solid Tumors
Link to Abstract. A PDF of the poster is available to download under the Resources tab
Contact Information
Name
Giri Ramsingh
Email
giri.ramsingh@gilead.com
You have chosen to your
information with
A Phase 2, Multi-Arm Study of Anti-CD47 Antibody Magrolimab in Combination with Docetaxel in Patients with Locally Advanced or Metastatic Solid Tumors
Team Members
Tizzy Jhaveri
Rebecca Chan